Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 14 Show results per page	View Search Criteria \| Help With Results

Last Modified: 7/1/1997


1.		Phase III Chemotherapy with Busulfan with or without Vitamin A for Chronic Myelogenous Leukemia (Summary Last Modified 07/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				SWOG-7984

Last Modified: 7/1/1997


2.		Phase III Postoperative Therapy with Vitamin-A vs No Further Treatment for Poor-Prognosis Stage I Melanoma (Summary Last Modified 07/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				SWOG-8049


3.		Phase III Surgery Followed by No Further Therapy vs Vitamin A vs ACT-D/DTIC for Recurrent Malignant Melanoma (Summary last modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				SWOG-8111


4.		Phase III Randomized Study of Immunotherapy with BCG with vs without Vitamin A for Resected, Poor-Prognosis Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								UARIZ-MEL-1

Last Modified: 9/21/2007


5.		Phase III Randomized Comparison of the Influence of Chemoprevention with Vitamin A and/or N-Acetylcysteine vs No Treatment on Development and Detection of Second Primary Cancers in Patients Curatively Treated for Laryngeal, Oral Cavity, and Nonsmall Cell Lung Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				75 and under								EORTC-08871 EORTC-24871

Last Modified: 10/1/1988


6.		Study of the Effect of Nutritional Intervention on Esophageal Cancer in Linxian, People's Republic of China (Summary Last Modified 10/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Completed				40 to 69								DCPC-CPSB-11204

Last Modified: 10/1/1989


7.		Phase III Study of Isotretinoin vs Vitamin A vs Placebo for the Prevention of Skin Cancer in Patients with a History of Basal and Squamous Cell Carcinoma of the Skin (Summary Last Modified 10/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				21 to less than 85								UARIZ-P89-0002 NCI-P89-0002

Last Modified: 6/1/1991


8.		Phase III Randomized, Double-Blind Study of Multiple Vitamins at the Recommended Daily Allowance (RDA) vs Multiple Vitamins at the RDA plus High-Dose Vitamins A, B6, C, and E in Patients with Transitional Cell Carcinoma of the Bladder (Summary Last Modified 06/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				any age								WVU-11715 NCI-V91-0025

Last Modified: 6/1/1997


9.		Phase III Randomized Chemoprevention Study of Long-Term, Low-Dose Isotretinoin vs Vitamin A in Patients with Premalignant Lesions of the Oral Cavity (Summary Last Modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				18 and over				Other				MDA-DM-90096 NCI-V93-0310

Last Modified: 4/1/1999 First Published: 11/1/1997


10.		Phase I/II Study of Chemopreventive Agents for the Prevention of Skin Cancer (Summary Last Modified 04/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Prevention				Completed				50-84				NCI				MDA-ID-95184 NCI-P97-0099

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute